Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

WKYMVM 2TFA(187986-17-0(free base))

🥰Excellent
Catalog No. T7484L

WKYMVM 2TFA is a N-formyl peptide receptor (FPR1) agonist.

WKYMVM 2TFA(187986-17-0(free base))

WKYMVM 2TFA(187986-17-0(free base))

🥰Excellent
Purity: 99.82%
Catalog No. T7484L
WKYMVM 2TFA is a N-formyl peptide receptor (FPR1) agonist.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$89In StockIn Stock
5 mg$342In StockIn Stock
10 mg$513In StockIn Stock
25 mg$762In StockIn Stock
50 mg$1,130In StockIn Stock
100 mg$1,530In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.82%
Appearance:solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
WKYMVM 2TFA is a N-formyl peptide receptor (FPR1) agonist.
In vitro
Neutrophils are activated by WKYMVM through FPRL1 and that FPRL2 is a chemotactic receptor transducing signals in myeloid cells[1].
In vivo
Using blood samples withdrawn from 28 AL patients and 31 healthy controls, found that, in the absence of exogenous WKYMVM, WKYMVM receptor and bactericidal activity did not differ between patients and controls.Addition of WKYMVM markedly increased the bactericidal activities of these cells in a dose-dependent manner.During induction chemotherapy, there were significant increases in bactericidal activity in the presence and absence of 1nM WKYMVM, with higher bactericidal activities at the time of complete remission than at the time of diagnosis or on day 15.During consolidation chemotherapy, WKYMVM had no effect on bactericidal activities.Patients showed significant increase in the concentrations of TNF alpha, IL-1b, IL-6 and IL-8, but significant decrease in the concentrations of IL-2, IL-4 and IL-12.TNF alpha, IL-1b and IL-6 showed significant negative correlations with bactericidal activities of patient neutrophils at time of diagnosis, and IL-4 showed a significant positive correlation with bactericidal activities,these findings indicate that WKYMVM enhances bactericidal activity in patients with AL[2].
Chemical Properties
Molecular Weight1084.16
FormulaC45H63F6N9O11S2
SmilesOC(=O)C(F)(F)F.OC(=O)C(F)(F)F.CSCC[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(N)=O
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 255 mg/mL (235.21 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM0.9224 mL4.6119 mL9.2237 mL46.1187 mL
5 mM0.1845 mL0.9224 mL1.8447 mL9.2237 mL
10 mM0.0922 mL0.4612 mL0.9224 mL4.6119 mL
20 mM0.0461 mL0.2306 mL0.4612 mL2.3059 mL
50 mM0.0184 mL0.0922 mL0.1845 mL0.9224 mL
100 mM0.0092 mL0.0461 mL0.0922 mL0.4612 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy WKYMVM 2TFA(187986-17-0(free base)) | purchase WKYMVM 2TFA(187986-17-0(free base)) | WKYMVM 2TFA(187986-17-0(free base)) cost | order WKYMVM 2TFA(187986-17-0(free base)) | WKYMVM 2TFA(187986-17-0(free base)) chemical structure | WKYMVM 2TFA(187986-17-0(free base)) in vivo | WKYMVM 2TFA(187986-17-0(free base)) in vitro | WKYMVM 2TFA(187986-17-0(free base)) formula | WKYMVM 2TFA(187986-17-0(free base)) molecular weight